730 View Street
Unit 420
Victoria, BC V8W 3Y7
Canada
778-600-0509
https://asepmedical.com
Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter:
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Dr. Robert E. W. Hancock FRSC, OC, Ph.D. | Founder, CEO & Chairman | 32,77k | N/A | N/A |
Ms. Jacqueline M. Tucker F.C.A., FCPA | Chief Financial Officer | 16,38k | N/A | 1956 |
Mr. Timothy W. Murphy | COO, Corp. Sec. & Director | 43,69k | N/A | N/A |
Dr. Evan Haney | Chief Scientific Officer | 56,24k | N/A | N/A |
Dr. Fadia Saad | Chief Bus. Devel. Officer | 131,06k | N/A | N/A |
Asep Medical Holdings Inc., together with its subsidiaries, focuses on developing early diagnostic and therapeutic solutions for sepsis treatment. It also provides antibacterial peptide coatings to treat antibiotic-resistant infections. The company was formerly known as Trenchant Life Sciences Investment Corp. Asep Medical Holdings Inc. was incorporated in 2020 and is headquartered in Victoria, Canada.
ASEP Medical Holdings Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.